These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18325070)

  • 21. Using disease progression models as a tool to detect drug effect.
    Mould DR; Denman NG; Duffull S
    Clin Pharmacol Ther; 2007 Jul; 82(1):81-6. PubMed ID: 17507925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designing follow-up intervals.
    Raab GM; Davies JA; Salter AB
    Stat Med; 2004 Oct; 23(20):3125-37. PubMed ID: 15449335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designs for phase I clinical trials with multiple courses of subjects at different doses.
    Fan SK; Wang YG
    Biometrics; 2007 Sep; 63(3):856-64. PubMed ID: 17403103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An adjustment for patient heterogeneity in the design of two-stage phase II trials.
    Sposto R; Gaynon PS
    Stat Med; 2009 Sep; 28(20):2566-79. PubMed ID: 19521973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining multiple comparisons and modeling techniques in dose-response studies.
    Bretz F; Pinheiro JC; Branson M
    Biometrics; 2005 Sep; 61(3):738-48. PubMed ID: 16135025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hybrid method for parameter estimation and its application to biomedical systems.
    Alonso H; Mendonça T; Rocha P
    Comput Methods Programs Biomed; 2008 Feb; 89(2):112-22. PubMed ID: 18083269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple testing to establish superiority/equivalence of a new treatment compared with k standard treatments for unbalanced designs.
    Kwong KS; Cheung SH; Chan WS
    Biometrics; 2004 Jun; 60(2):491-8. PubMed ID: 15180675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proof of concept and dose estimation with binary responses under model uncertainty.
    Klingenberg B
    Stat Med; 2009 Jan; 28(2):274-92. PubMed ID: 19012269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A geometric confidence ellipse approach to the estimation of the ratio of two variables.
    Walter SD; Gafni A; Birch S
    Stat Med; 2008 Dec; 27(28):5956-74. PubMed ID: 18720350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bayesian bootstrap estimation of ROC curve.
    Gu J; Ghosal S; Roy A
    Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonparametric estimation of a multivariate distribution in the presence of censoring.
    Hanley JA; Parnes MN
    Biometrics; 1983 Mar; 39(1):129-39. PubMed ID: 6871341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonparametric methods for measurements below detection limit.
    Zhang D; Fan C; Zhang J; Zhang CH
    Stat Med; 2009 Feb; 28(4):700-15. PubMed ID: 19035469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing a Partial Ordering of Population Means with Application to Inference about Growth Habits of Cowpea Genotypes.
    Jeske DR; Wang G; McGiffen ME
    Biometrics; 2007 Dec; 63(4):1278-82. PubMed ID: 17573862
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting apoptosis as an approach for gastrointestinal cancer therapy.
    Qiao L; Wong BC
    Drug Resist Updat; 2009 Jun; 12(3):55-64. PubMed ID: 19278896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A nonparametric smoothing method for assessing GEE models with longitudinal binary data.
    Lin KC; Chen YJ; Shyr Y
    Stat Med; 2008 Sep; 27(22):4428-39. PubMed ID: 18613210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical analysis of combined dose effects for experiments with two agents.
    Wagenpfeil S; Treiber U; Lehmer A
    Artif Intell Med; 2006 May; 37(1):65-71. PubMed ID: 16497492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A nonparametric mean estimator for judgment poststratified data.
    Wang X; Lim J; Stokes L
    Biometrics; 2008 Jun; 64(2):355-63. PubMed ID: 18325072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curtailed two-stage designs in Phase II clinical trials.
    Chi Y; Chen CM
    Stat Med; 2008 Dec; 27(29):6175-89. PubMed ID: 18816510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential use of cetrimonium bromide as an apoptosis-promoting anticancer agent for head and neck cancer.
    Ito E; Yip KW; Katz D; Fonseca SB; Hedley DW; Chow S; Xu GW; Wood TE; Bastianutto C; Schimmer AD; Kelley SO; Liu FF
    Mol Pharmacol; 2009 Nov; 76(5):969-83. PubMed ID: 19654225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes.
    Chareyron S; Alamir M
    J Theor Biol; 2009 Jun; 258(3):444-54. PubMed ID: 18655792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.